Malt Lymphoma

• CLINICAL_TRIALS research · 2026-02-12
  Clinical Trial Update: Molecular and Cellular Characterization of MALT Lymphoma

  This clinical trial update outlines the molecular and cellular characterization study of MALT lymphoma conducted by the International Extran…

• CLINICAL_TRIALS trial_result · 2026-01-07
  Clinical Trial Update: Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma [Phase 2]

  Phase 2 trial evaluating ultra-low-dose orbital radiation therapy for Stage I-IV indolent B-cell non-Hodgkin lymphoma and mantle cell lympho…

• CLINICAL_TRIALS trial_result · 2024-09-04
  Clinical Trial Update: A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma [Phase 3]

  Phase 3 trial evaluating the effect of Vitamin D on progression-free survival in indolent non-Hodgkin lymphoma has completed with results po…

• CLINICAL_TRIALS trial_result · 2021-05-07
  Clinical Trial Update: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Phase 2]

  Phase 2 trial evaluating lenalidomide with low-dose dexamethasone and rituximab in rituximab-resistant, non-aggressive B-cell lymphomas; com…

• CLINICAL_TRIALS trial_result · 2020-10-27
  Clinical Trial Update: Lenalidomide and Low-dose Cyclophosphamide for MALT Lymphoma [Phase 2]

  Phase 2 trial investigating lenalidomide plus low-dose cyclophosphamide for MALT lymphoma; current status is unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2016-11-10
  Clinical Trial Update: Helicobacter Pylori Antibiotic Susceptibility Testing of Korea

  This clinical trial update describes a Korean study investigating antibiotic susceptibility testing for Helicobacter pylori. The conditions …

• CLINICAL_TRIALS trial_result · 2016-03-28
  Clinical Trial Update: Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma [NA]

  A completed clinical trial evaluated whether eradicating Helicobacter pylori can aid treatment of early-stage primary MALT lymphoma.

• CLINICAL_TRIALS trial_result · 2013-11-27
  Clinical Trial Update: Velcade in MALT Lymphoma Patients [Phase 2]

  Phase 2 trial evaluating Velcade (bortezomib) in patients with MALT lymphoma has completed.

• CLINICAL_TRIALS trial_result · 2013-06-11
  Clinical Trial Update: Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults [Phase 1]

  Phase 1 study reports safety and immunogenicity data for an investigational Helicobacter pylori vaccine in healthy adults.